Evidence map›Paper›PMID 40861610›Full record

ArticleCureus2025

Short Supply-Driven Modifications to Blood Culture Practice and Their Clinical Impact: A Single-Center Time-Series Study.

Daisuke Ono, Kazuyuki Mimura, Yuki Watanabe, Eiyu Ebata, Kei Yamamoto, Yusuke Nishida, Yasufumi Suzuki, Masumi Ogawa, Shinichiro Fukuda, Kunihisa Tsukada and 2 more

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Daisuke OnoInfectious Diseases and Infection Control/Infectious Diseases, Saitama Medical Center, Saitama Medical University, Saitama, JPN.
Kazuyuki MimuraGeneral Internal Medicine, Saitama Medical Center, Saitama Medical University, Saitama, JPN.
Yuki WatanabeClinical Laboratory, Saitama Medical Center, Saitama Medical University, Saitama, JPN.
Eiyu EbataClinical Laboratory/Microbiology, Saitama Medical Center, Saitama Medical University, Saitama, JPN.
Kei YamamotoGeneral Internal Medicine, Saitama Medical Center, Saitama Medical University, Saitama, JPN.
Yusuke NishidaGeneral Internal Medicine/Infectious Diseases, Saitama Medical Center, Saitama Medical University, Saitama, JPN.
Yasufumi SuzukiMedical Informatics, Saitama Medical Center, Saitama Medical University, Saitama, JPN.
Masumi OgawaInternal Medicine, Self-Defense Forces Central Hospital, Tokyo, JPN.
Shinichiro FukudaPharmacy, Saitama Medical Center, Saitama Medical University, Saitama, JPN.
Kunihisa TsukadaInfectious Diseases and Infection Control/Infectious Diseases, Saitama Medical Center, Saitama Medical University, Saitama, JPN.
Hideaki OkaGeneral Internal Medicine, Saitama Medical Center, Saitama Medical University, Saitama, JPN.
Kyosuke TakeshitaClinical Laboratory, Saitama Medical Center, Saitama Medical University, Saitama, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBlood cultures are essential for identifying bloodstream infections and guiding treatment. A global BD BACTEC™ bottle (BD, Franklin Lakes, NJ, US) shortage disrupted diagnostics, including at the Saitama Medical Center. During the shortage period, clinicians were instructed to prioritize cultures based on clinical necessity and infection focus, often opting for single-set submissions or deferring testing. This study examined changes in blood culture practices during the shortage period.

methodsWe conducted a retrospective observational study to analyze the blood culture data collected between January 1 and October 31, 2024. Five outcome indicators were evaluated: submission count, single-set submission rate, submission episode count, true-positivity rate, and contamination rate. The analyses were limited to patients aged ≥15 years to minimize pediatric-related biases. Segmented regression with Prais-Winsten adjustment was used to perform interrupted time-series analysis and account for autocorrelation and seasonal trends. Additionally, the detection frequencies of true bloodstream pathogens were compared between the pre-shortage and shortage periods using Fisher's exact test.

resultsOf the 7,073 total submissions, 5,592 adult blood culture sets were included in the analysis. The Durbin-Watson statistic ranged from 1.92 to 2.37 across models, indicating no significant autocorrelation in residuals. Weekly submission counts declined significantly during the shortage period (p = 0.005) and showed a marginal post-shortage decline (p = 0.052). Single-set submission rates increased significantly during the shortage (p = 0.025) but plateaued afterward. Submission episode counts declined significantly during the shortage period (p = 0.035) and continued to decrease after the shortage (p = 0.034), although no immediate-level change was observed at the shortage onset (p = 0.398). True-positivity rates increased during (p = 0.010) and after (p = 0.028) the shortage, which indicated improved diagnostic yield per test. Contamination rates remained stable throughout the experiment. No significant changes were observed in the distribution of key bloodstream pathogens, such as

conclusionsThe bottle shortage prompted fewer submissions, more selective sampling, and higher positivity rates without increased contamination. These findings highlight the value of targeted diagnostic stewardship and the need for adaptable, data-driven protocols to sustain care quality during future supply disruptions.

Indexed as

antimicrobial stewardshipblood culture bottlebloodstream infectionsdata-driven protocolssupply shortage

Identifiers

PMID40861610
PMCPMC12372575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.